Is NRC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NRC. It does not provide personalized investment advice.

NRC (NRC Health Common Stock) Stock Analysis - Financials

NRC Health Common Stock (NRC) is a publicly traded Healthcare sector company. As of October 15, 2026, NRC trades at $21.06 with a market cap of $451.90M and a P/E ratio of 0.41. NRC moved +3.23% today. Year to date, NRC is +17.08%; over the trailing twelve months it is +84.37%. Its 52-week range spans $9.76 to $23.68. Analyst consensus is buy with an average price target of $26.00. Rallies surfaces NRC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are NRC's key financials?

NRC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NRC recently traded at $21.06. Market cap is $451.90M. P/E ratio is 0.41. Revenue is $140.00M.

NRC Key Metrics

Key financial metrics for NRC
Metric	Value
Price	$21.06
Market Cap	$451.90M
P/E Ratio	0.41
EPS	$49.74
Dividend Yield	0.16%
52-Week High	$23.68
52-Week Low	$9.76
Volume	26.93K
Avg Volume	0
Revenue (TTM)	$140.00M
Net Income	$5.86M
Gross Margin	61.75%

NRC Analyst Consensus

1 analysts cover NRC: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $26.00.

Common questions about NRC

What are NRC's key financials?: NRC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NRC recently traded at $21.06. Market cap is $451.90M. P/E ratio is 0.41. Revenue is $140.00M.
Is NRC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NRC. It does not provide personalized investment advice.